We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer.
- Authors
Kaye, Stan B.; Lubinski, Jan; Matulonis, Ursula; Ang, Joo Ern; Gourley, Charlie; Karlan, Beth Y.; Amnon, Amit; Bell-McGuinn, Katherine M.; Chen, Lee-May; Friedlander, Michael; Safra, Tamar; Vergote, Ignace; Wickens, Mark; Lowe, Elizabeth S.; Carmichael, James; Kaufman, Bella
- Publication
Journal of Clinical Oncology, 2012, Vol 30, Issue 4, p372
- ISSN
0732-183x
- Publication type
article
- DOI
10.1200/JCO.2011.36.9215